Ergoteles’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,000
Closed -$527K 1075
2023
Q1
$527K Buy
17,000
+5,900
+53% +$73.3K 0.02% 715
2022
Q4
$93.6K Sell
11,100
-41,080
-79% -$350K ﹤0.01% 1234
2022
Q3
$510K Sell
52,180
-44,620
-46% -$512K 0.02% 751
2022
Q2
$1.16M Buy
+96,800
New +$567K 0.03% 484

Other funds holding BMEA

Ergoteles's BMEA Position: Q2 2023 in Review

Ergoteles sold out of Biomea Fusion (BMEA) in Q2 2023, closing a stake of 17,000 shares — an estimated $527K sold.

Ergoteles first reported a position in BMEA in Q2 2022 and held it in 4 quarters. The position peaked at $1.16M in Q2 2022. 90 funds tracked by Wall St. Rank hold BMEA as of Q2 2023.

  • Ergoteles reported no remaining Biomea Fusion position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 17,000 Biomea Fusion shares in Q2 2023, an estimated $527K.
  • Ergoteles first reported a position in Biomea Fusion in Q2 2022 and held it in 4 quarters.
  • Ergoteles's Biomea Fusion position peaked at $1.16M in Q2 2022.
  • 90 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.